Dominique Valteau-Couanet
Overview
Explore the profile of Dominique Valteau-Couanet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
4362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chupin A, Dudoignon B, Couque N, Bokov P, Mayer S, Simaga F, et al.
J Pediatr Hematol Oncol
. 2025 Feb;
PMID: 39961018
Alterations of PHOX2B function is associated with a wide range of diseases, including congenital central hypoventilation syndrome (CCHS) and neural crest-derived tumors, from low-grade (ganglioneuromas) to malignant forms (neuroblastomas). We...
2.
Rossillon L, Edeline V, Agrigoroaie L, Pasqualini C, Berlanga P, Bolle S, et al.
Pediatr Blood Cancer
. 2024 Oct;
72(1):e31350.
PMID: 39402749
Background: Persistent metaiodobenzylguanidine (mIBG)-positive skeletal metastases post induction in high-risk neuroblastoma correlate with a poor outcome. The aim of this study was to investigate the potential rationale for a prospective...
3.
Espinoza A, Bagatell R, McHugh K, Naranjo A, Van Ryn C, Rojas Y, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31218.
PMID: 39072986
Background: Image-defined risk factors (IDRFs) were promulgated for predicting the feasibility and safety of complete primary tumor resection in children with neuroblastoma (NB). There is limited understanding of the impact...
4.
Felix A, Dichamp C, Michaux K, Minard-Colin V, Sarnacki S, Lacour B, et al.
Pediatr Blood Cancer
. 2024 May;
71(8):e31037.
PMID: 38745371
No abstract available.
5.
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles A, Thebaud E, et al.
Eur J Cancer
. 2024 Mar;
202:114001.
PMID: 38489858
Background: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this...
6.
Chaix J, Schleiermacher G, Corradini N, Andre N, Thebaud E, Gambart M, et al.
Eur J Cancer
. 2024 Feb;
201:113923.
PMID: 38377775
Introduction: Despite poor survival for patients with relapsed or refractory neuroblastoma, only 10-16% of patients are reported to be included in early phase trials. This study aimed to explore the...
7.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, et al.
J Clin Oncol
. 2024 Jan;
42(10):1135-1145.
PMID: 38190578
Purpose: Outcomes for children with relapsed and refractory high-risk neuroblastoma (RR-HRNB) remain dismal. The BEACON Neuroblastoma trial (EudraCT 2012-000072-42) evaluated three backbone chemotherapy regimens and the addition of the antiangiogenic...
8.
Lecompte J, Sarnacki S, Irtan S, Piolat C, Scalabre A, Talon I, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001727
Objectives: To assess the efficacy of thoracoscopy and the outcome for children with thoracic neurogenic tumors. Methods: We performed a retrospective review of 15 European centers between 2000 and 2020...
9.
Bougas N, Allodji R, Fayech C, Haddy N, Mansouri I, Journy N, et al.
Br J Cancer
. 2023 Aug;
129(8):1298-1305.
PMID: 37604931
Background: We aimed to study adherence to cardiac screening in long-term childhood cancer survivors (CCS) at high risk of cardiomyopathy. Methods: This study involved 976 5-year CCS at high risk...
10.
Sevrin F, Kolesnikov-Gauthier H, Cougnenc O, Bogart E, Schleiermacher G, Courbon F, et al.
Pediatr Blood Cancer
. 2023 Aug;
70(11):e30615.
PMID: 37574821
Purpose: We report the results of the French multicentric phase II study MIITOP (NCT00960739), which evaluated tandem infusions of I-metaiodobenzylguanidine (mIBG) and topotecan in children with relapsed/refractory metastatic neuroblastoma (NBL)....